Amprenavir resistance imparted by the I50V mutation in HIV-1 protease can be suppressed by the N88S mutation.
Lam
Eric
E
Parkin
Neil T
NT
D001216:Asparagine / Q000235:genetics; D002219:Carbamates; D024882:Drug Resistance, Viral / Q000235:genetics*; D005663:Furans; D016333:HIV Protease / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology; D006801:Humans; D007532:Isoleucine / Q000235:genetics; D008826:Microbial Sensitivity Tests; D009154:Mutation; D012694:Serine / Q000235:genetics; D013449:Sulfonamides / Q000494:pharmacology*; D014633:Valine / Q000235:genetics
D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D007532:Isoleucine; D012694:Serine; C095108:amprenavir; D001216:Asparagine; D016333:HIV Protease; D014633:Valine